Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression
Ana Paula Mendes-Silva1, Kelly Silva Pereira1, Gesiane Thamire Tolentino-Araujo1
1Graduate Program in Molecular Medicine, Federal University of Minas Gerais School of Medicine, Belo Horizonte, MG, Brazil.
Objective:
The clinical-epidemiological relationship between major depressive disorder (MDD) and Alzheimer disease (AD) suggests that they may share common neurobiologic abnormalities.
Methods:
The authors conducted a systematic review and identified microRNAs abnormally expressed in both AD and MDD. The pattern of microRNA regulation in each disorder and the genes regulated by each microRNA and the biologic processes and pathways regulated by these genes were identified.
Results:
Seventy-four microRNAs were abnormally expressed in AD and 30 in MDD; 7 were common for both disorders (hsa-let-7f-5p, hsa-miR-664a-3p, hsa-miR-361-5p, hsa-let-7g-5p, hsa-let-7d-5p, hsa-miR-191-5p, hsa-miR-26b-5p). These microRNAs interact with 45 validated genes, and the main biologic pathways and processes regulated by them were proteostasis control, maintenance of genomic integrity, regulation of transcriptional activity, immune-inflammatory control, and neurotrophic support.
Conclusion:
The current results suggest that the maintenance of genomic integrity, proteostasis control, immune-inflammatory regulation, and neurotrophic support are key neurobiologic links between these conditions. A comprehensive hypothetical model for the interaction between MDD, aging, and the development of AD is provided.
Insights
Major depressive disorder (MDD) and Alzheimer disease (AD) share common neurobiologic abnormalities. Key links include genomic integrity, proteostasis, immune regulation, and neurotrophic support.
Area of Science:
- Neurobiology
- Genetics
- Psychiatry
Background:
- Clinical and epidemiological data suggest shared neurobiological underpinnings between major depressive disorder (MDD) and Alzheimer disease (AD).
- Understanding these commonalities may elucidate disease mechanisms and identify therapeutic targets for both conditions.
Purpose of the Study:
- To systematically review and identify microRNAs (miRNAs) abnormally expressed in both AD and MDD.
- To analyze the regulatory patterns, target genes, and biological pathways associated with these shared miRNAs.
Main Methods:
- Systematic literature review to identify miRNAs dysregulated in AD and MDD.
- Bioinformatic analysis to determine common miRNAs, their target genes, and associated biological processes.
Main Results:
- Seven miRNAs (e.g., hsa-let-7f-5p, hsa-miR-191-5p) were found to be commonly dysregulated in both AD and MDD.
- These miRNAs target 45 genes involved in crucial biological pathways including proteostasis, genomic integrity, immune-inflammatory control, and neurotrophic support.
Conclusions:
- Maintenance of genomic integrity, proteostasis control, immune-inflammatory regulation, and neurotrophic support represent key neurobiological links between MDD and AD.
- A hypothetical model is proposed to explain the interaction between MDD, aging, and AD development.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Alzheimer's Disease: Treatment
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression

